氨基烷基吲哚与NG108-15细胞中非大麻素结合位点的结合。
Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
作者信息
Stark S, Pacheco M A, Childers S R
机构信息
Neuroscience Program, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.
出版信息
Cell Mol Neurobiol. 1997 Oct;17(5):483-93. doi: 10.1023/a:1026306804802.
Abstract
- Aminoalkylindoles, typified by WIN 55212-2, bind to G protein-coupled cannabinoid receptors in brain. Although cannabinoids inhibit adenylyl cyclase in NG108-15 neuroblastoma x glioma hybrid cells, cannabinoid receptor binding in these cells has not been described previously. This study compares pharmacological characteristics of [3H]WIN 55212-2 binding sites in rat cerebellar membranes and in NG108-15 membranes. 2. Although the KD of specified [3H]WIN 55212-2 binding was similar in brain and NG108-15 membranes, the Bmax was 10 times lower in NG108-15 than in cerebellar membranes. In both brain and NG108-15 membranes, aminoalkylindole analogues were relatively potent in displacing [3H]WIN 55212-2 binding. However, IC50 values for more traditional cannabinoids were significantly higher in NG108-15 membranes than in brain, e.g., the Ki values for CP55,940 were 1.2 nM in brain and > 5000nM in NG108-15 membranes. Moreover, sodium and GTP-gamma-S decreased [3H]WIN 55212-2 binding in brain but not in NG108-15 membranes. 3. These data suggest that WIN 55212-2 does not label traditional cannabinoid receptors in NG108-15 cells and that these novel aminoalkylindole binding sites are not coupled to G proteins.
摘要
- 以WIN 55212-2为代表的氨基烷基吲哚可与脑中的G蛋白偶联大麻素受体结合。尽管大麻素可抑制NG108-15神经母细胞瘤x胶质瘤杂交细胞中的腺苷酸环化酶，但此前尚未描述过这些细胞中大麻素受体的结合情况。本研究比较了大鼠小脑膜和NG108-15膜中[3H]WIN 55212-2结合位点的药理学特性。2. 尽管特定[3H]WIN 55212-2结合的解离常数（KD）在脑和NG108-15膜中相似，但NG108-15中的最大结合容量（Bmax）比小脑膜中的低10倍。在脑和NG108-15膜中，氨基烷基吲哚类似物在取代[3H]WIN 55212-2结合方面相对有效。然而，更传统大麻素的半数抑制浓度（IC50）值在NG108-15膜中显著高于脑，例如，CP55,940的抑制常数（Ki）值在脑中为1.2 nM，在NG108-15膜中>5000 nM。此外，钠和鸟苷三磷酸γ-硫酯（GTP-γ-S）可降低脑中[3H]WIN 55212-2的结合，但不影响NG108-15膜中的结合。3. 这些数据表明，WIN 55212-2在NG108-15细胞中未标记传统大麻素受体，且这些新的氨基烷基吲哚结合位点未与G蛋白偶联。
相似文献
1
Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Cell Mol Neurobiol. 1997 Oct;17(5):483-93. doi: 10.1023/a:1026306804802.
2
Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Biol Reprod. 1996 Oct;55(4):756-61. doi: 10.1095/biolreprod55.4.756.
3
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. doi: 10.1016/j.ejphar.2007.06.047. Epub 2007 Jul 4.
4
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Mol Pharmacol. 2001 Jul;60(1):155-63.
5
Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Naunyn Schmiedebergs Arch Pharmacol. 2000 Jan;361(1):19-24. doi: 10.1007/s002109900147.
6
Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
J Neurochem. 2000 Apr;74(4):1627-35. doi: 10.1046/j.1471-4159.2000.0741627.x.
7
Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Br J Pharmacol. 1998 Nov;125(6):1345-51. doi: 10.1038/sj.bjp.0702204.
8
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Life Sci. 1996;59(8):659-68. doi: 10.1016/0024-3205(96)00347-5.
9
Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.
J Neurochem. 1994 May;62(5):1773-82. doi: 10.1046/j.1471-4159.1994.62051773.x.
10
2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.
Biochem Biophys Res Commun. 1996 Dec 4;229(1):58-64. doi: 10.1006/bbrc.1996.1757.
引用本文的文献
1
Design, synthesis, and evaluation of substituted alkylindoles that activate G protein-coupled receptors distinct from the cannabinoid CB and CB receptors.
Eur J Med Chem. 2023 Mar 5;249:115123. doi: 10.1016/j.ejmech.2023.115123. Epub 2023 Jan 26.
2
WIN55212-2 Modulates Intracellular Calcium via CB Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells.
Cells. 2022 Sep 21;11(19):2947. doi: 10.3390/cells11192947.
3
The Spicy Story of Cannabimimetic Indoles.
Molecules. 2021 Oct 14;26(20):6190. doi: 10.3390/molecules26206190.
4
Efficacy in CB1 receptor-mediated signal transduction.
Br J Pharmacol. 2004 Aug;142(8):1209-18. doi: 10.1038/sj.bjp.0705881.
本文引用的文献
1
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.
Eur J Pharmacol. 1996 Jun 20;307(1):97-105. doi: 10.1016/0014-2999(96)00211-7.
2
Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice.
Brain Res. 1996 Jan 8;706(1):13-20. doi: 10.1016/0006-8993(95)01113-7.
3
Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
J Pharmacol Exp Ther. 1993 Mar;264(3):1352-63.
4
Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
Brain Res. 1993 Feb 12;603(1):102-10. doi: 10.1016/0006-8993(93)91304-b.
5
6
Effects of anandamide on cannabinoid receptors in rat brain membranes.
Biochem Pharmacol. 1994 Feb 11;47(4):711-5. doi: 10.1016/0006-2952(94)90134-1.
7
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7242-6. doi: 10.1073/pnas.92.16.7242.
8
Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
Mol Pharmacol. 1984 Nov;26(3):532-8.
9
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds.
Life Sci. 1984 Oct 22;35(17):1803-10. doi: 10.1016/0024-3205(84)90278-9.
10
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108. doi: 10.1016/0006-2952(73)90196-2.
Zotero 插件